Recent Innovations in Biopharmaceutical and Biomarker Technologies

Recent Innovations in Biopharmaceutical and Biomarker Technologies

RELEASE DATE
14-Jun-2019
REGION
Global
Research Code: D759-00-09-00-00
SKU: HC03182-GL-TA_23264

$950.00

Special Price $712.50 save 25 %

In stock
SKU
HC03182-GL-TA_23264

$950.00

$712.50 save 25 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

This edition of the Life Science, Health & Wellness TechVision Opportunity Engine (TOE) comprises 26 recent technology innovations across the biopharmaceutical and biomarker platforms for research and clinical applications across the global healthcare industry. The research captures key innovation aspects such as technology readiness levels, market potential, funding, disruptive potential, mega trend impact, and regional adoption scenarios to evaluate the innovation index for each technology profile. A summary of the innovation index has also been provided in a visual radar format.

The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Biopharmaceuticals, biomarkers, start-ups, allogene, CAR-T, cell therapy, Gossamer, immunology, Magnolia, neuroscience, Akouos, AAV, gene therapy, Akero, fibroblast, Protochips, e-chips, Hookipa, arenavirus, Aviana, acoustic, Cue Health, Diagnostic, Co-Diagnostic, PCR, Ontera, Nanopore, Selux, Phenotyping, Springworks, rare disease, Lung Therapeutics, Abacus, Abionic, sepsis, Blusense, SAW, infections, Aelix, HIV, Gammadelta, immunotherapy, Quell, cure.fit, artificial intelligence, Mitra, cancer, ATGC, agriculture,Eyestem, Aura, stem cells

Table of Contents

Innovators in US & Canada

  • Allogene Therapeutics
  • Allogene Therapeutics
  • Gossamer Bio
  • Gossamer Bio
  • Magnolia Neurosciences Corporation
  • Magnolia Neurosciences Corporation
  • Akouos
  • Akouos
  • Akero Therapeutics
  • Akero Therapeutics
  • Protochips
  • Protochips
  • HOOKIPA Pharma Inc.
  • HOOKIPA Pharma Inc.
  • Aviana Molecular Technologies LLC
  • Aviana Molecular Technologies LLC
  • Cue Health Inc.
  • Cue Health Inc.
  • Co-Diagnostics Inc.
  • Co-Diagnostics Inc.
  • Ontera Inc.
  • Ontera Inc.
  • SeLux Diagnostics Inc.
  • SeLux Diagnostics Inc.
  • SpringWorks Therapeutics
  • SpringWorks Therapeutics
  • Lung Therapeutics
  • Lung Therapeutics

Innovators in Europe

  • Abacus Diagnostica Oy
  • Abacus Diagnostica Oy
  • Abionic SA
  • Abionic SA
  • BluSense Diagnostic ApS
  • BluSense Diagnostic ApS
  • SAW Diagnostics Limited
  • SAW Diagnostics Limited
  • Aelix Therapeutics
  • Aelix Therapeutics
  • GammaDelta Therapeutics
  • GammaDelta Therapeutics
  • Quell Therapeutics
  • Quell Therapeutics

Innovators in India

  • Cure.Fit
  • Cure.Fit
  • Mitra Biotech
  • Mitra Biotech
  • ATGC Biotech
  • ATGC Biotech
  • Eyestem
  • Eyestem
  • Aura Biotechnologies
  • Aura Biotechnologies

Innovation Radar

  • Innovation Radar

Appendix

  • Summary of the Scoring Methodology
  • Key Contacts
  • Key Contacts (continued)
  • Key Contacts (continued)
  • Key Contacts (continued)
  • Key Contacts (continued)
  • Key Contacts (continued)
  • Key Contacts (continued)
  • Key Contacts (continued)
  • Key Contacts (continued)
  • Your F&S Thought Leader
Related Research
This edition of the Life Science, Health & Wellness TechVision Opportunity Engine (TOE) comprises 26 recent technology innovations across the biopharmaceutical and biomarker platforms for research and clinical applications across the global healthcare industry. The research captures key innovation aspects such as technology readiness levels, market potential, funding, disruptive potential, mega trend impact, and regional adoption scenarios to evaluate the innovation index for each technology profile. A summary of the innovation index has also been provided in a visual radar format. The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Biopharmaceuticals, biomarkers, start-ups, allogene, CAR-T, cell therapy, Gossamer, immunology, Magnolia, neuroscience, Akouos, AAV, gene therapy, Akero, fibroblast, Protochips, e-chips, Hookipa, arenavirus, Aviana, acoustic, Cue Health, Diagnostic, Co-Diagnostic, PCR, Ontera, Nanopore, Selux, Phenotyping, Springworks, rare disease, Lung Therapeutics, Abacus, Abionic, sepsis, Blusense, SAW, infections, Aelix, HIV, Gammadelta, immunotherapy, Quell, cure.fit, artificial intelligence, Mitra, cancer, ATGC, agriculture,Eyestem, Aura, stem cells
More Information
No Index No
Podcast No
Industries Healthcare
WIP Number D759-00-09-00-00
Is Prebook No
Ti Codes D759,D904,D913,D91A,D91B,D932,D933,D935,D936,D937